Avantor Inc
Research Avantor Inc (AVTR) on Bullrun: market cap USD 9.76B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAVTR
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Market capUSD 9.76B
- Financial periodQ2 2026
- RevenueUSD 1.69B
- Net incomeUSD 38.10M
- Free cash flowUSD 140.60M
- Gross margin31.7%
Valuation Snapshot
latest market cap is USD 9.76B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 6.55B | -USD 530.20M | USD 495.00M | 32.7% | -0.78 | USD 365.40M | USD 3.95B | USD 5.57B |
| FY2024 | USD 6.78B | USD 711.50M | USD 692.00M | 33.6% | 1.04 | USD 261.90M | USD 4.06B | USD 5.96B |
| FY2023 | USD 6.97B | USD 321.10M | USD 723.60M | 33.9% | 0.47 | USD 262.90M | USD 5.54B | USD 5.25B |
| FY2022 | USD 7.51B | USD 686.50M | USD 710.20M | 34.6% | 1.01 | USD 372.90M | USD 6.29B | USD 4.86B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 9.76B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 7.82B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 14.34B | 20.3 | n/a | n/a |
| 2023 | 2023-12-29 | USD 15.44B | 42.3 | n/a | n/a |
| 2022 | 2022-12-30 | USD 14.22B | 23.7 | n/a | n/a |
| 2021 | 2021-12-31 | USD 25.69B | 49.6 | n/a | n/a |
About Avantor Inc
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
Related stock research
Other Healthcare stocks
Align Technology Inc (ALGN)
Angiodynamic Inc (ANGO)
Aptargroup Inc (ATR)
Atricure Inc (ATRC)
Azenta Inc (AZTA)
Baxter International Inc (BAX)
Becton Dickinson & Company (BDX)
Biolife Solutions Inc (BLFS)
Bionano Genomics Inc (BNGO)
Cooper Companies Inc (COO)
Daxor Corp (DXR)
Ekso Bionics Holdings Inc (EKSO)
Frequently asked questions
What is Avantor Inc's market cap?
Avantor Inc's market capitalization is USD 9.76B.
What does Avantor Inc do?
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.